134 related articles for article (PubMed ID: 25326)
21. Quantitative TLC of salicylazosulfapyridine.
Powell DR; Burton BA
J Pharm Sci; 1974 Aug; 63(8):1290-3. PubMed ID: 4153030
[No Abstract] [Full Text] [Related]
22. Identification and characterization of potential impurities of quetiapine fumarate.
Stolarczyk EU; Kaczmarek L; Eksanow K; Kubiszewski M; Glice M; Kutner A
Pharm Dev Technol; 2009; 14(1):27-37. PubMed ID: 18815940
[TBL] [Abstract][Full Text] [Related]
23. Impurity profile study of zaleplon.
Bharathi Ch; Prabahar KJ; Prasad ChS; Kumar MS; Magesh S; Handa VK; Dandala R; Naidu A
J Pharm Biomed Anal; 2007 May; 44(1):101-9. PubMed ID: 17367980
[TBL] [Abstract][Full Text] [Related]
24. Identification, isolation, synthesis and characterization of impurities of quetiapine fumarate.
Bharathi Ch; Prabahar KJ; Prasad ChS; Srinivasa Rao M; Trinadhachary GN; Handa VK; Dandala R; Naidu A
Pharmazie; 2008 Jan; 63(1):14-9. PubMed ID: 18271296
[TBL] [Abstract][Full Text] [Related]
25. Physico-chemical and analytical studies on plafibride.
Torres A; Ristol P; Ribalta JM
Arzneimittelforschung; 1981; 31(10a):1786-90. PubMed ID: 7198455
[TBL] [Abstract][Full Text] [Related]
26. Isolation and characterization of process-related impurities and degradation products in larotaxel.
Che X; Shen L; Xu H; Liu K
J Pharm Biomed Anal; 2011 Jul; 55(5):1190-6. PubMed ID: 21530132
[TBL] [Abstract][Full Text] [Related]
27. Identification, isolation, and synthesis of seven novel impurities of anti-diabetic drug Repaglinide.
Kancherla P; Keesari S; Alegete P; Khagga M; Das P
Drug Test Anal; 2018 Jan; 10(1):212-221. PubMed ID: 28421713
[TBL] [Abstract][Full Text] [Related]
28. Identification and characterization of the process-related impurities in fasudil hydrochloride by hyphenated techniques using a quality by design approach.
Song M; Chen YQ; Lu PB; Hang TJ
J Sep Sci; 2014 Apr; 37(7):758-63. PubMed ID: 24470347
[TBL] [Abstract][Full Text] [Related]
29. [A contribution to the identification of the oral antidiabetic agent tolbutamide. 1st communication].
Oelschläger H; Blume H
Arzneimittelforschung; 1976; 26(3):303-12. PubMed ID: 989317
[TBL] [Abstract][Full Text] [Related]
30. Estimation of impurity profiles of drugs and related materials: part 19: theme with variations. Identification of impurities in 3-oxosteroids.
Görög S; Babják M; Balogh G; Brlik J; Dravecz F; Gazdag M; Horváth P; Laukó A; Varga K
J Pharm Biomed Anal; 1998 Dec; 18(4-5):511-25. PubMed ID: 9919951
[TBL] [Abstract][Full Text] [Related]
31. Determination of p-cresidine in FD&C red no. 40 by the diazotization and coupling procedure followed by reversed-phase high-performance liquid chromatography.
Richfield-Fratz N; Bailey JE
J Chromatogr; 1987 Sep; 405():283-94. PubMed ID: 3693468
[TBL] [Abstract][Full Text] [Related]
32. Forced degradation and impurity profiling: recent trends in analytical perspectives.
Jain D; Basniwal PK
J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
[TBL] [Abstract][Full Text] [Related]
33. All on one high-performance thin-layer chromatography plate: solvent-free nanomole-scaled on-surface synthesis, workup and online high-resolution mass spectrometry for elucidation of two new degradation products in an ifosfamide formulation.
Yüce I; Morlock GE
J Chromatogr A; 2018 Oct; 1572():145-151. PubMed ID: 30166113
[TBL] [Abstract][Full Text] [Related]
34. Isolation and characterization of some potential impurities in ropinirole hydrochloride.
Sahasrabuddhey B; Nautiyal R; Acharya H; Khyade S; Luthra PK; Deshpande PB
J Pharm Biomed Anal; 2007 Mar; 43(4):1587-93. PubMed ID: 17207602
[TBL] [Abstract][Full Text] [Related]
35. High-speed liquid chromatographic analysis of sulfasalazine (salicylazosulfapyridine).
Bighley LD; McDonnell JP
J Pharm Sci; 1975 Sep; 64(9):1549-53. PubMed ID: 241835
[TBL] [Abstract][Full Text] [Related]
36. Preparation and properties of ryodipine, an effective antihypertensive agent.
Kastron VV; Dubur GJ; Shatz VD; Yagupolsky LM
Arzneimittelforschung; 1985; 35(4):668-72. PubMed ID: 4015732
[TBL] [Abstract][Full Text] [Related]
37. Photodegradation of sulfasalazine and its human metabolites in water by UV and UV/peroxydisulfate processes.
Ji Y; Yang Y; Zhou L; Wang L; Lu J; Ferronato C; Chovelon JM
Water Res; 2018 Apr; 133():299-309. PubMed ID: 29407711
[TBL] [Abstract][Full Text] [Related]
38. Characterization and quantitative determination of impurities in piperaquine phosphate by HPLC and LC/MS/MS.
Dongre VG; Karmuse PP; Ghugare PD; Gupta M; Nerurkar B; Shaha C; Kumar A
J Pharm Biomed Anal; 2007 Jan; 43(1):186-95. PubMed ID: 16916594
[TBL] [Abstract][Full Text] [Related]
39. Identification, synthesis and quantification of process-related impurities in auraptene.
Li YG; Chen HF; Tu MZ; Zhang PZ; Wang XY; Yuan JB; Yang WL
J Pharm Biomed Anal; 2011 Sep; 56(2):191-9. PubMed ID: 21705169
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
